Wellness Focus Cayman Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Focus Cayman Islands.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 27, 2026

6 hours ago

Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations

GlobeNewswire

6 hours ago

Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program

GlobeNewswire

6 hours ago

TRIMEDX named recipient of Modern Healthcare’s Best in Business Award in Cybersecurity category

GlobeNewswire

6 hours ago

Imviva Biotech Receives FDA Orphan Drug Designation for CTD402 for the Treatment of T-Cell Leukemia and Lymphoma

GlobeNewswire

6 hours ago

SRx Health Solutions Allocates Further Capital to its Digital Asset Treasury Hedging Strategy, Bringing Total Allocation to $18 Million

GlobeNewswire

6 hours ago

Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome

GlobeNewswire

6 hours ago

CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer

GlobeNewswire

6 hours ago

NewGen to Execute Up to US$2 Million Share Repurchase Program Through Benchmark

GlobeNewswire

6 hours ago

Hydreight Technologies Inc. Announces Closing of Oversubscribed $15 Million Bought Deal LIFE Offering

GlobeNewswire

7 hours ago

ABLi Therapeutics Completes Collaboration Agreement with The Michael J. Fox Foundation to include Risvodetinib in Path to Prevention Platform Trial

GlobeNewswire

7 hours ago

Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’

GlobeNewswire

7 hours ago

Science 37 Appoints Kelly Johnston McKee as VP of Strategy & Transformation

GlobeNewswire

7 hours ago

Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026

GlobeNewswire

7 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

GlobeNewswire

7 hours ago

Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN

GlobeNewswire

7 hours ago

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide

GlobeNewswire

7 hours ago

Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverage Distribution Across Canada Through Walmart Canada and McKesson Canada

GlobeNewswire

7 hours ago

Cloudbreak Pharma Announces Successful End-of-Phase-2 Meeting and Alignment with FDA on Phase 3 Path Forward for CBT-004

GlobeNewswire

7 hours ago

Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)

GlobeNewswire

7 hours ago

Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy (HCM)

GlobeNewswire